Astera Labs (NASDAQ:ALAB) Stock Price Up 9.8% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares rose 9.8% during mid-day trading on Friday . The stock traded as high as $321.65 and last traded at $310.40. Approximately 6,271,666 shares were traded during mid-day trading, an increase of 18% from the average daily volume of 5,312,975 shares. The stock had previously closed at $282.82.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on ALAB shares. Needham & Company LLC lifted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective on the stock in a research report on Monday, August 17th. Finally, Susquehanna upped their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Up 9.8%

The stock has a market capitalization of $53.85 billion, a P/E ratio of 153.66 and a beta of 3.77. The stock has a 50 day simple moving average of $332.37 and a two-hundred day simple moving average of $253.97.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 592,244 shares of company stock valued at $209,729,973 in the last 90 days. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently bought and sold shares of ALAB. Royal Bank of Canada increased its position in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its stake in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after acquiring an additional 1,977 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.